Presentation TCT 2014 Systemic Therapies for the At-Risk Patient: From Darapladib to Anti-inflammatories and PCSK9 Inhibitors Presenter: Harvey D. White September 14, 2014 REGISTER for free or LOG IN to view this content Plaque Modification Presentation TCT 2014 Up Next Presentation TCT 2014 Hyperemic vs Resting Indices: Comparison in Stable and ACS Populations Presenter: Rajesh K Kharbanda September 14, 2014 More slides + Presentation TCT 2014 Is There a Role for Cilostazol with Contemporary DES? Presenter: Young-Hoon Jeong September 14, 2014 Presentation TCT 2014 Guideline Update: Aortic and Mitral Valve Disease and the 2014 AHA/ACC Guideline for Valvular Heart Disease Presenter: Patrick T. O'Gara September 15, 2014 We Recommend
Presentation TCT 2014 Hyperemic vs Resting Indices: Comparison in Stable and ACS Populations Presenter: Rajesh K Kharbanda September 14, 2014
Presentation TCT 2014 Is There a Role for Cilostazol with Contemporary DES? Presenter: Young-Hoon Jeong September 14, 2014
Presentation TCT 2014 Guideline Update: Aortic and Mitral Valve Disease and the 2014 AHA/ACC Guideline for Valvular Heart Disease Presenter: Patrick T. O'Gara September 15, 2014